Compare · BFLY vs GEHC
BFLY vs GEHC
Side-by-side comparison of Butterfly Network Inc. (BFLY) and GE HealthCare Technologies Inc. (GEHC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BFLY and GEHC operate in Medical Electronics (Health Care), so they compete in similar markets.
- GEHC is the larger of the two at $29.42B, about 24.6x BFLY ($1.19B).
- Over the past year, BFLY is up 93.3% and GEHC is down 9.8% - BFLY leads by 103.1 points.
- GEHC has been more active in the news (7 items in the past 4 weeks vs 5 for BFLY).
- GEHC has more recent analyst coverage (25 ratings vs 8 for BFLY).
PerformanceBFLY+93.33%GEHC-9.75%
2025-06-09+0.00%2026-06-08
- Company
- Butterfly Network Inc.
- GE HealthCare Technologies Inc.
- Price
- $4.78+4.71%
- $64.68+0.04%
- Market cap
- $1.19B
- $29.42B
- 1M return
- +12.85%
- +5.47%
- 1Y return
- +93.33%
- -9.75%
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 5
- 7
- Recent ratings
- 8
- 25
BFLY
Butterfly Network Inc.
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; and Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smart phone or tablet. The company serves healthcare practitioners. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.
Latest BFLY
- Deputy General Counsel Caezza Nicholas sold $7,831 worth of shares (1,733 units at $4.52), decreasing direct ownership by 0.56% to 310,307 units (SEC Form 4) to satisfy tax liability
- Director Neubauer Caroll H was granted 73,170 shares (SEC Form 4)
- SEC Form 3 filed by new insider Neubauer Caroll H
- Butterfly Network to Participate in the William Blair 46th Annual Growth Stock Conference
- Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts
- A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
- The Future of Intoxication Detection May Be in Your Voice
- Butterfly Network Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Butterfly Network Appoints Caroll H. Neubauer to Board of Directors
- Butterfly Network to Present at the Bank of America Securities 2026 Global Healthcare Conference
Latest GEHC
- GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities
- SEC Form SD filed by GE HealthCare Technologies Inc.
- Director Lobo Kevin bought $641,800 worth of shares (10,000 units at $64.18), increasing direct ownership by 229% to 14,363 units (SEC Form 4)
- GE HealthCare upgraded by UBS with a new price target
- CEO, AIS Rackliffe Philip was granted 16,458 shares, increasing direct ownership by 62% to 43,187 units (SEC Form 4)
- CEO, Patient Care Solutions Bankes Jeannette covered exercise/tax liability with 5,535 shares, decreasing direct ownership by 13% to 38,357 units (SEC Form 4) (tax withholding)
- Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts
- Amendment: SEC Form SCHEDULE 13G/A filed by GE HealthCare Technologies Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by GE HealthCare Technologies Inc.
- Director Hochman Rodney F bought $100,365 worth of shares (1,618 units at $62.03) (SEC Form 4)